# CRCA Tracking Error: Up vs Down Days

> Over the 90 days to Nov 4, 2026, CRCA missed two times CRCL's daily return by 7.5 basis points a day on average, on its NAV. No fund is recommended.

Data as of Nov 4, 2026. Rebuilt every trading night.

As of Nov 4, 2026 . Rebuilt every trading night.

## CRCA daily tracking

Over the 90 days to Nov 4, 2026, CRCA missed two times CRCL's daily return by 7.5 basis points a day on average, on its NAV.

| Window | Read on | Average daily miss, bp | Signed average, bp | Tracking error | Up days, bp | Down days, bp | Up less down, bp | Confidence |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 30 days to Nov 4, 2026: 21 of 22 days, from Oct 7, 2026 | NAV (stated) | 7.2 | −7.2 | 0.89% | −6.4 (9 days) | −8.0 (11 days) | +1.6 | Not enough days |
| 30 days to Nov 4, 2026, 22 daily returns | closing price | 26.2 | −5.8 | 5.50% | −11.8 (10 days) | −1.9 (11 days) | −9.9 | Not significant (t −0.6) |
| 90 days to Nov 4, 2026: 61 of 63 days, from Aug 7, 2026 | NAV (stated) | 7.5 | −7.5 | 0.87% | −6.9 (30 days) | −8.2 (30 days) | +1.3 | Not significant (t 0.9) |
| 90 days to Nov 4, 2026, 63 daily returns | closing price | 29.7 | −6.7 | 5.79% | −13.6 (32 days) | 0.0 (30 days) | −13.6 | Not significant (t −1.5) |
| 180 days to Nov 4, 2026: 122 of 124 days, from May 11, 2026 | NAV (stated) | 8.4 | −8.3 | 1.04% | −8.2 (55 days) | −8.5 (65 days) | +0.3 | Not significant (t 0.2) |
| 180 days to Nov 4, 2026, 124 daily returns | closing price | 31.0 | −7.2 | 6.23% | −10.9 (57 days) | −2.8 (65 days) | −8.1 | Not significant (t −1.1) |
| 1 year to Nov 4, 2026: 247 of 251 days, from Nov 5, 2025 | NAV (stated) | 8.8 | −8.7 | 1.07% | −8.9 (118 days) | −8.6 (126 days) | −0.3 | Not significant (t −0.3) |
| 1 year to Nov 4, 2026, 251 daily returns | closing price | 34.0 | −9.1 | 6.80% | −14.8 (121 days) | −3.2 (127 days) | −11.6 | Significant (t −2.1) |

### CRCA's largest daily misses

The 5 days CRCA strayed furthest from its daily target in the 1 year to Nov 4, 2026, each on its NAV where ETFIQ holds it, else its closing price.

| # | Day | Read on | CRCL moved | Target | CRCA returned | Miss |
| --- | --- | --- | --- | --- | --- | --- |
| 1 | Oct 5, 2026 | closing price | +2.52% | +5.05% | +4.59% | −0.46 pts |
| 2 | Feb 13, 2026 | NAV | +6.02% | +12.04% | +11.67% | −0.37 pts |
| 3 | Feb 6, 2026 | NAV | +13.56% | +27.12% | +26.79% | −0.32 pts |
| 4 | Mar 5, 2026 | closing price | +0.45% | +0.89% | +1.20% | +0.31 pts |
| 5 | Apr 2, 2026 | NAV | −0.53% | −1.06% | −1.37% | −0.31 pts |

### Method

The daily miss is CRCA's return each day less two times CRCL's return that day. A basis point is a hundredth of a percentage point. Each window is read twice where ETFIQ holds both NAVs: on NAVs, and on closing prices. CRCA ranks 280 of 494 2x leveraged ETFs on its 90-day average daily miss. Up days and down days split the miss by whether CRCL rose or fell; Significant means the gap is at least two standard errors from zero. The average miss carries its sign: a negative one is what the fund kept below its target each day, its fees and financing among it. Not every fund here has traded for a year, and a number over eight months does not order against one over twelve. This page lists each fund with its window and dates instead of ranking them. It becomes a ranking on the night four of them share a full year. Every window ETFIQ can measure for CRCA is listed.

### Where to next

### Sources

Links are sources, not endorsements.

A ranking is not a recommendation or an opinion. ETFIQ is an independent publisher, not an adviser. Standards and sources

---

Source: ETFIQ, independent ETF data. Recomputed nightly from public filings and prices.
Cite: ETFIQ, CRCA daily tracking, listed by window, data as of Nov 4, 2026. https://etfiq.com/funds/crca/tracking/
Licence: https://etfiq.com/license/ Data ETFIQ computes is free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.
HTML: https://etfiq.com/funds/crca/tracking/